CFLT · As filed with the SEC
Confluent cash flow statement, by quarter
The statement as Confluent presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Consolidated Statements of Cash Flows · USD thousands
| USD thousands | Q4 2025† 3 months ended Dec 31, 2025 | Q3 2025† 3 months ended Sep 30, 2025 | Q2 2025† 3 months ended Jun 30, 2025 | Q1 2025 3 months ended Mar 31, 2025 | Q4 2024† 3 months ended Dec 31, 2024 | Q3 2024† 3 months ended Sep 30, 2024 | Q2 2024† 3 months ended Jun 30, 2024 | Q1 2024 3 months ended Mar 31, 2024 |
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net loss | (79,247)† | (66,504)† | (81,950)† | (67,574) | (88,054)† | (74,144)† | (89,900)† | (92,967) |
| Adjustments to reconcile net loss to cash provided by (used in) operating activities: | ||||||||
| Depreciation and amortization | 7,786† | 7,821† | 7,344† | 6,605 | 6,234† | 5,702† | 5,842† | 4,311 |
| Net accretion of discounts on marketable securities | (4,441)† | (5,060)† | (5,952)† | (6,847) | (8,205)† | (9,294)† | (9,871)† | (10,396) |
| Amortization of debt issuance costs | 969† | 968† | 957† | 945 | 966† | 964† | 953† | 953 |
| Amortization of deferred contract acquisition costs | 14,848† | 15,208† | 14,323† | 13,931 | 14,213† | 13,949† | 13,334† | 12,762 |
| Non-cash operating lease costs | 1,090† | 1,046† | 1,089† | 1,075 | 1,172† | 940† | 969† | 885 |
| Lease abandonment charges | — | — | — | — | 0† | 0† | 0† | 0 |
| Stock-based compensation, net of amounts capitalized | 101,625† | 101,128† | 101,997† | 92,575 | 102,924† | 98,307† | 99,107† | 95,322 |
| Deferred income taxes | — | 310† | 177† | (17,338) | 46† | (111)† | (273)† | 615 |
| Other | 1,100† | 3,025† | 1,107† | 454 | 1,675† | 485† | 361† | 849 |
| Changes in operating assets and liabilities, net of effects of business combinations: | ||||||||
| Accounts receivable | (35,102)† | 291† | (60,321)† | 15,414 | (36,327)† | (21,577)† | (58,018)† | 29,360 |
| Deferred contract acquisition costs | (26,768)† | (19,439)† | (15,236)† | (10,410) | (15,974)† | (12,244)† | (15,296)† | (9,732) |
| Prepaid expenses and other assets | 4,292† | (11,213)† | (19,988)† | 1,515 | 1,205† | (2,135)† | 3,703† | (1,929) |
| Accounts payable | 8,893† | 491† | 5,356† | (1,274) | (8,159)† | 1,231† | 11,987† | (4,932) |
| Accrued expenses and other liabilities | 27,861† | (14,694)† | 21,149† | (49,828) | 32,861† | (10,363)† | 46,893† | (43,752) |
| Operating lease liabilities | (2,321)† | (2,191)† | (2,205)† | (2,177) | (4,191)† | (2,020)† | (1,994)† | (1,935) |
| Deferred revenue | 23,375† | 19,614† | 50,268† | (3,820) | 34,825† | 25,923† | 793† | (5,368) |
| Net cash provided by (used in) operating activities | 42,112† | 30,801† | 18,115† | (26,754) | 35,211† | 15,613† | 8,590† | (25,954) |
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capitalization of internal-use software costs | (6,152)† | (5,409)† | (6,191)† | (4,806) | (5,420)† | (5,669)† | (4,776)† | (5,539) |
| Purchases of marketable securities | (352,708)† | (414,962)† | (465,993)† | (405,235) | (367,357)† | (273,169)† | (455,883)† | (443,307) |
| Sales of marketable securities | 0† | 0† | — | — | 2,567† | 0† | — | — |
| Maturities of marketable securities | 341,540† | 375,177† | 458,470† | 299,467 | 381,127† | 374,281† | 403,489† | 432,267 |
| Purchases of investments in privately-held companies | 0† | (750)† | — | — | 0† | (1,250)† | — | — |
| Purchases of property and equipment | (442)† | (807)† | (919)† | (1,429) | (669)† | (607)† | (1,105)† | (186) |
| Cash paid for business combinations, net of cash acquired | 0† | — | — | — | 0† | (115,516)† | 0† | 0 |
| Net cash used in investing activities | (17,762)† | (46,751)† | (8,489)† | (112,003) | 10,248† | (21,930)† | (46,531)† | (16,765) |
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Proceeds from issuance of common stock upon exercise of vested options | 24,551† | 10,041† | 6,062† | 16,606 | 19,504† | 8,835† | 13,096† | 14,401 |
| Repurchases of unvested common stock | — | — | — | — | 0† | 0† | 0† | 0 |
| Proceeds from issuance of common stock under employee stock purchase plan | 0† | 9,731† | 0† | 14,195 | 0† | 8,367† | 0† | 15,603 |
| Net cash provided by financing activities | 24,551† | 19,772† | 6,062† | 30,801 | 19,504† | 17,202† | 13,096† | 30,004 |
| Effect of exchange rate changes on cash and cash equivalents | — | (876)† | 1,342† | 537 | (1,589)† | 393† | (200)† | (673) |
| Net (decrease) increase in cash and cash equivalents | 48,673† | 2,946† | 17,030† | (107,419) | 63,374† | 11,278† | (25,045)† | (13,388) |
| Cash and cash equivalents at beginning of period | 298,537 | 295,591 | 278,561 | 385,980 | 322,606 | 311,328 | 336,373 | 349,761 |
| Cash and cash equivalents at end of period | 347,210 | 298,537 | 295,591 | 278,561 | 385,980 | 322,606 | 311,328 | 336,373 |
| Supplementary cash flow disclosures: | ||||||||
| Cash paid for: | ||||||||
| Income taxes | 6,284† | 3,032† | 4,067† | 2,328 | 2,471† | 4,093† | 3,328† | 1,814 |
| Non-cash investing and financing activities: | ||||||||
| Stock-based compensation capitalized as internal-use software costs | 4,597† | 3,753† | 4,931† | 3,342 | 4,681† | 5,108† | 4,505† | 5,597 |
| Issuance of common stock in connection with a business combination | 0† | — | — | — | 0† | — | — | — |
| Right-of-use assets obtained in exchange for new operating lease liabilities | 0† | — | — | — | 0† | — | — | — |
| Vesting of early exercised stock options | 0† | 0† | 0† | 126 | 307† | 291† | 301† | 316 |
† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.